Co-Authors
This is a "connection" page, showing publications co-authored by Licia Mota and Ana Reis.
Connection Strength
1.340
-
Pregnancy Outcomes and Child Development Effects of SARS-CoV-2 Infection (PROUDEST Trial): Protocol for a Multicenter, Prospective Cohort Study. JMIR Res Protoc. 2021 Apr 20; 10(4):e26477.
Score: 0.470
-
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry. RMD Open. 2021 01; 7(1).
Score: 0.230
-
SARS-CoV-2/DENV co-infection: a series of cases from the Federal District, Midwestern Brazil. BMC Infect Dis. 2021 Jul 31; 21(1):727.
Score: 0.120
-
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study. JMIR Res Protoc. 2021 Mar 04; 10(3):e24211.
Score: 0.117
-
A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study. JMIR Res Protoc. 2020 Dec 15; 9(12):e24357.
Score: 0.115
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146.
Score: 0.059
-
Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students' Educational Routines and Mental Health: Protocol for a Web-Based Survey Study. JMIR Res Protoc. 2021 04 09; 10(4):e24617.
Score: 0.059
-
Mental Health and Burnout Syndrome Among Postgraduate Students in Medical and Multidisciplinary Residencies During the COVID-19 Pandemic in Brazil: Protocol for a Prospective Cohort Study. JMIR Res Protoc. 2021 Jan 19; 10(1):e24298.
Score: 0.058
-
Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study. JMIR Res Protoc. 2020 Oct 14; 9(10):e23532.
Score: 0.057
-
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Adv Rheumatol. 2020 06 09; 60(1):32.
Score: 0.055